Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards

Gilead CEO To Step Down

By Catherine Sbeglia | July 26, 2018

CEO and President of Gilead Sciences John Milligan is looking forward to stepping down at the end of the year. Milligan who has served as CEO for two years, and according to Gilead Lead Independent Director John Cogan, has contributed to the company for nearly 30 years, commented, “I’m looking forward to a well-deserved break and moving on.”

In 2016, Milligan replaced John Martin as CEO, who moved to the position of executive chairman. The company’s announcement also stated that Martin will step down as chairman when a new CEO is named, allowing for a “natural transitions point from his successive roles as CEO, executive chairman and chairman.”

Gilead’s announcement comes only a few months after R&D Chief Norbert Bischofberger relinquished his role at the company.

Cogan stated “on behalf of the entire board, I want to thank [Milligan] […] and commend him for operating throughout his career with the highest personal and professional integrity. Given his longstanding dedication to Gilead, it is no surprise that [Milligan] is committed to facilitating a seamless transition for all of our stakeholders, as we work to identify his successor.”  

(Source: Gilead Sciences; Business Wire)

Related Articles Read More >

Lab image
What is needed to develop disease-modifying therapies for Parkinson’s and Alzheimer’s 
Johnson & Johnson
Feds halt J&J COVID-19 vaccine due to blood clot concern
pharmaceuticals
Analyzing FDA guidance on DDI studies for therapeutic proteins
Pfizer-BioNTech
Pfizer asks FDA to authorize its COVID-19 vaccine for younger teens

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Drug Discovery and Development
  • Enews Signup
  • Contact Us
  • R&D World
  • Pharmaceutical Processing
  • Drug Delivery Business News

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards